Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
30.98
+1.03 (3.44%)
At close: Apr 28, 2026, 4:00 PM EDT
29.50
-1.48 (-4.78%)
After-hours: Apr 28, 2026, 4:54 PM EDT
Surrozen Market Cap
Surrozen has a market cap or net worth of $355.86 million as of April 28, 2026. Its market cap has increased by 356.86% in one year.
Market Cap
355.86M
Enterprise Value
271.41M
1-Year Change
356.86%
Ranking
Category
Stock Price
$30.98
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $355.86M, an increase of 194.94%. That is a compound annual growth rate of 22.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 344.03M | 63.28% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 341.08M |
| Bicycle Therapeutics | 337.38M |
| Greenwich LifeSciences | 335.42M |
| Nautilus Biotechnology | 331.60M |
| Cabaletta Bio | 328.40M |
| Rezolute | 322.00M |
| Inhibikase Therapeutics | 320.45M |
| NervGen Pharma | 317.25M |